Waldenstrom Macroglobulinemia

What is Waldenstrom Macroglobulinemia?

Waldenstrom macroglobulinemia (WM), sometimes known as ”Lymphoplasmacytic Lymphoma” is a rare type of cancer that affects the immune system. It is a type of lymphoma, which is a cancer of the white blood cells. In WM, the cancer cells produce too much of a protein called immunoglobulin M (IgM), which can lead to problems with bleeding and clotting, as well as problems with the immune system. Symptoms of WM may include fatigue, weight loss, night sweats, and an enlarged spleen. Treatment for WM may include chemotherapy, radiation therapy, and/or targeted therapies. In some cases, a stem cell transplant may be recommended. It is important to work with a healthcare team to determine the best treatment plan for you.

Table of Contents

Waldenstrom macroglobulinemia is considered a type of non-Hodgkin lymphoma. It’s sometimes called lymphoplasmacytic lymphoma, which is a type of cancer that affects the lymphatic system, which is a network of organs and tissues that helps protect the body from infection and disease. It is characterized by the presence of abnormal lymphocytes (a type of white blood cell) and plasma cells (a type of immune cell) in the blood and lymphatic tissues.

Signs and Symptoms of Waldenstrom of Macroglobulinemia

Waldenstrom macroglobulinemia is a rare type of blood cancer that affects a type of white blood cell called a lymphocyte. Symptoms of Waldenstrom macroglobulinemia may include:

Fatigue
Weakness
Loss of appetite
Weight loss
Night sweats
Fever
Numbness, tingling, or weakness in the hands or feet
Enlarged lymph nodes
Rash or purpura (purple or red spots on the skin)
Heavy periods in women
Confusion or difficulty thinking
Shortness of breath

If you are experiencing any of these symptoms, it is important to consult a doctor. They can perform tests to determine the cause and recommend the appropriate treatment.

Causes of Waldenstrom Macroglobulinemia

The exact cause of this type of cancer is not known to health experts, however they merely know that one initially one white blood cell develops errors (mutations) in its genetic code/makeup. The errors order the cell to divide/ multiply rapidly, and the cell starts execution.

Cancer cells multiply through a process called cell division. This process involves the cell replication its DNA and then dividing into two daughter cells. This process is controlled by a group of proteins called cyclins and cyclin-dependent kinases (CDKs). In normal cells, this process is regulated and occurs at a controlled rate. However, in cancer cells, the regulation of cell division is disrupted and the cells begin to divide and multiply at an uncontrolled rate. This uncontrolled cell division and proliferation of cancer cells leads to the growth and spread of the cancerous tumor.

As cancer cells divide before being mature and die as normal cells, they eventually accumulate overwhelming production of healthy cells. In the bone marrow (the soft blood-producing tissue) that fills in the center of most of your bones — Waldenstrom macroglobulinemia cells crowd out healthy blood cells.

What’s wrong with W.M. cancer cells?

W.M. cancer cells do not affect your immune system, as they produce antibodies like a healthy white blood cell. The wrong thing they do is, produce abnormal proteins that the body can’t use. The protein immunoglobulin M (IgM) accumulates in the blood, impairs circulation, and causes complications.

Risk Factors of Waldenstrom Macroglobulinemia

Waldenstrom macroglobulinemia (WM) is a rare form of blood cancer that is characterized by the production of abnormal, monoclonal (single type) immunoglobulin M (IgM) proteins in the blood. The exact cause of WM is unknown, but it is thought to be related to the abnormal proliferation of certain immune cells (B cells) in the bone marrow.

There are several potential risk factors for developing WM, including:

Age: WM is more common in people over the age of 50.
Gender: Men are more likely to develop WM than women.
Family history: A family history of WM or other blood disorders may increase the risk of developing WM.
Genetic factors: Some people with WM may have inherited a genetic predisposition to the condition.
Exposure to certain chemicals or toxins: Exposure to certain chemicals or toxins may increase the risk of developing WM.
Certain medical conditions: People with autoimmune diseases or certain infections may be at an increased risk for developing WM.

It is important to note that the majority of people with WM do not have any known risk factors, and the cause of their condition remains unknown.

Diagnosis of Waldenstrom Macroglobulinemia

The above-mentioned symptoms and signs help diagnose W.M. Cancer. However, tests and lab procedures are more helpful to arrive at an accurate diagnostic result. Generally, the following tests are conducted to diagnose it;

Blood Tests:

There are several blood tests that can be used to diagnose Waldenstrom macroglobulinemia, including:

Complete blood count (CBC): This test measures the number and types of cells in the blood, including red blood cells, white blood cells, and platelets. An increase in the number of unhealthy white blood cells and lymphocytes (a type of white blood cell) may be a sign of Waldenstrom macroglobulinemia.
Blood protein electrophoresis: This test separates proteins in the blood into different groups based on their charge and size. An excess of IgM (Immunoglobulin M) protein in the blood may be a sign of Waldenstrom macroglobulinemia.

It’s important to note that these tests are usually only used to help confirm a diagnosis of Waldenstrom macroglobulinemia. Additional tests may be necessary to fully evaluate the extent of the disease and to determine the best course of treatment.

Bone Marrow Tests:

This test involves taking a small sample of bone marrow and examining it under a microscope. The bone marrow sample can help determine the presence of cancer cells. During a bone marrow biopsy, your doctor uses a needle to extract some of your bone marrow from your hipbone. The sample is examined to look for cancer cells. If any are detected, advanced laboratory analysis can help your doctor understand the cancer cells’ characteristics, including their genetic mutations.

Imaging Tests:

Imaging tests can help your doctor determine whether cancer has spread to other areas of your body. Imaging tests may include computerized tomography (CT) scans or positron emission tomography (PET) scans. Some imaging tests that may be used to diagnose Waldenstrom Macroglobulinemia include:

CT scan: This is a type of X-ray that produces detailed images of the body’s internal organs, bones, and tissues.
MRI: This test uses magnetic fields and radio waves to create detailed images of the body’s organs and tissues.
PET scan: This test uses a small amount of radioactive material to produce detailed images of the body’s organs and tissues.
X-ray: This test uses a small amount of radiation to produce images of the body’s organs and tissues.
Ultrasound: This test uses high-frequency sound waves to produce images of the body’s organs and tissues.

Treatment of Waldenstrom Macroglobulinemia

There are several methods for the treatment of W.M. cancer depending on the nature and severity of the condition. Treatment options for Waldenstrom macroglobulinemia may include:

Treatment of a Dormant Waldenstrom Macroglobulinemia

A dormant Waldenstrom Macroglobulinemia means, a patient showing IgM protein in his blood, but did not report any symptoms or complaints related to their condition. Additionally, the patient appeared to have a good quality of life, with no limitations in their daily activities or physical functioning. They were able to perform their usual work and leisure activities without difficulty. In such cases, your doctor may recommend blood tests every few months to monitor your condition. You may go years without needing further treatment.

Plasma Exchange Method

Plasma exchange is a treatment option for WM that involves removing the plasma (the liquid portion of the blood) from the patient’s body and replacing it with donated plasma or a plasma substitute. This process helps to lower the levels of abnormal proteins (IgM) in the blood, which can improve symptoms and help the patient feel better.

Plasma exchange is typically performed through a process called plasmapheresis, which involves inserting a catheter into a vein in the patient’s arm and using a machine to separate the plasma from the blood cells. The plasma is then removed and replaced with donated plasma or a plasma substitute, and the blood cells are returned to the patient’s body.

Plasma exchange may be used as a standalone treatment or in combination with other therapies, such as chemotherapy or immune suppression. It is typically performed on an outpatient basis, but may be done in a hospital setting if the patient is severely ill.

Overall, plasma exchange can be an effective treatment for WM, but it is not a cure. The long-term outlook for patients with WM depends on the stage and severity of their disease, as well as their overall health and response to treatment.

Chemotherapy

Chemotherapy is a treatment option for Waldenstrom Macroglobulinemia, a type of blood cancer that affects the immune system. It involves the use of drugs to kill cancer cells or inhibit their growth. Chemotherapy may be used alone or in combination with other treatments, such as monoclonal antibody therapy or stem cell transplant.

The specific chemotherapy drugs and treatment schedule will depend on the individual patient’s specific circumstances and the stage of their disease. Common chemotherapy drugs used to treat Waldenstrom Macroglobulinemia include bendamustine, chlorambucil, cyclophosphamide, fludarabine, and rituximab.

Chemotherapy can have side effects, such as nausea, vomiting, hair loss, fatigue, and an increased risk of infection. These side effects can be managed with medications and supportive care. It is important for patients to discuss the potential risks and benefits of chemotherapy with their healthcare team before starting treatment.

Targetting Therapy

Targeted therapy drugs kill cancer cells by focusing on the specific abnormalities present in the cancer cells that allow them to survive. Targeted therapy drugs may be used alone or combined with other medications, such as chemotherapy or biological therapy, as an initial treatment for Waldenstrom macroglobulinemia or in cases where cancer returns despite treatment. There are several targeted therapy drugs used to treat Waldenstrom Macroglobulinemia, including:

Ibrutinib: This drug works by inhibiting an enzyme called Bruton’s tyrosine kinase, which is involved in the growth and survival of cancer cells. It is taken orally in pill form.
Idelalisib: This drug works by inhibiting an enzyme called PI3K, which is involved in the growth and survival of cancer cells. It is taken orally in pill form.
Venetoclax: This drug works by inhibiting the protein BCL-2, which helps cancer cells survive and grow. It is taken orally in pill form.
Rituximab: This drug is a monoclonal antibody that targets and destroys cancer cells. It is given through intravenous injection.
Alemtuzumab: This drug is another monoclonal antibody that targets and destroys cancer cells. It is given through intravenous injection.

It is important to note that these drugs may not be suitable for everyone and can have side effects. It is important to discuss the potential benefits and risks with a healthcare provider before starting any treatment.

Biological Theraphy

Bilogical therapy drugs are those, which use your immune system to kill cancer-affected cells. They are generally used to tackle the condition in its initial or recurrent stage. These drugs are used alone or with a combination of other drugs.

There are several biological therapies that can be used to treat WM, including:

Monoclonal antibody therapy: This type of therapy uses monoclonal antibodies, which are man-made versions of immune proteins, to target specific cells or proteins in the body. Examples of monoclonal antibody therapies used to treat WM include rituximab and ofatumumab.
Immunomodulatory drugs: These drugs work by altering the activity of the immune system. Examples of immunomodulatory drugs used to treat WM include lenalidomide and thalidomide.
Proteasome inhibitors: These drugs work by inhibiting proteasomes, which are proteins that break down other proteins in the body. Proteasome inhibitors used to treat WM include bortezomib and carfilzomib.

It’s important to note that the most appropriate treatment for a patient with WM will depend on a variety of factors, including the patient’s age, overall health, and the severity of their condition. A healthcare provider will be able to recommend the best treatment options for an individual patient.

Bone marrow transplantation

A bone marrow transplant is a medical procedure in which healthy bone marrow stem cells are transplanted into a patient’s body to replace damaged or diseased bone marrow. This procedure is often used to treat Waldenstrom Macroglobulinemia, a rare type of blood cancer that affects the production of white blood cells and antibodies.

The bone marrow transplant process begins with the patient undergoing chemotherapy or radiation therapy to destroy the cancer cells in the body. Once the cancer cells have been eliminated, the patient is given healthy bone marrow stem cells through a vein or injected into the bone. The healthy stem cells travel to the bone marrow and begin to produce new blood cells, replacing the damaged or diseased cells.

The success of a bone marrow transplant for Waldenstrom Macroglobulinemia depends on several factors, including the patient’s overall health, the type of bone marrow donor, and the timing of the transplant. Some patients may experience side effects such as infections, bleeding, or graft-versus-host disease, which occurs when the transplanted bone marrow attacks the patient’s body.

Overall, a bone marrow transplant can be a potentially life-saving treatment option for patients with Waldenstrom Macroglobulinemia, but it is important to discuss the risks and benefits with a medical professional before making a decision.